Inefficient alveolar wound repair contributes to the development of pulmonary fibrosis. Hepatocyte growth factor (HGF) is a potent growth factor for alveolar type II epithelial cells (AECII) and may improve repair and reduce fibrosis. We studied whether targeted gene transfer of HGF specifically to AECII improves lung fibrosis in bleomycin-induced lung fibrosis. A plasmid encoding human HGF expressed from the human surfactant protein C promoter (pSpC-hHGF) was designed, and extracorporeal electroporation-mediated gene transfer of HGF specifically to AECII was performed 7 days after bleomycin-induced lung injury in the rat. Animals were killed 7 days after hHGF gene transfer. Electroporation-mediated HGF gene transfer resulted in HGF expression specifically in AECII at biologically relevant levels. HGF gene transfer reduced pulmonary fibrosis as assessed by histology, hydroxyproline determination, and design-based stereology compared with controls. Our results indicate that the antifibrotic effect of HGF is due in part to a reduction of transforming growth factor-β1, modulation of the epithelial–mesenchymal transition, and reduction of extravascular fibrin deposition. We conclude that targeted HGF gene transfer specifically to AECII decreases bleomycin-induced lung fibrosis and may therefore represent a novel cell-specific gene transfer technology to treat pulmonary fibrosis.
Get full access to this article
View all access options for this article.
References
1.
AdamsonI.Y., BakowskaJ.1999. Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin. Am. J. Pathol., 155:949–954.
2.
AdamsonI.Y., YoungL., BowdenD.H.1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol., 130:377–383.
3.
AdamsonI.Y., HedgecockC., BowdenD.H.1990. Epithelial cell–fibroblast interactions in lung injury and repair. Am. J. Pathol., 137:385–392.
4.
AntoniouK.M., PatakaA., BourosD., SiafakasN.M.2007. Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther., 20:453–461.
5.
AshcroftT., SimpsonJ.M., TimbrellV.1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 41:467–470.
6.
BardelliA., LongatiP., AlberoD.et al.1996. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J., 15:6205–6212.
7.
BergeronA., SolerP., KambouchnerM.et al.2003. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10. Eur. Respir. J., 22:69–76.
8.
ChambersR.C.2003. Role of coagulation cascade proteases in lung repair and fibrosis. Eur. Respir. J., 22:33s–35s.
9.
ChambersR.C.2008. Procoagulant signalling mechanisms in lung inflammation and fibrosis: Novel opportunities for pharmacological intervention?Br. J. Pharmacol., 153:S367–S378.
10.
ChaudharyN.I., RothG.J., HilbergF.et al.2007. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur. Respir. J., 29:976–985.
11.
DayR.M., SoonL., BreckenridgeD.et al.2002. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene, 21:2201–2211.
12.
du BoisR.M., WellsA.U.2001. Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis. Eur. Respir. J. Suppl., 32:43s–55s.
13.
EitzmanD.T., McCoyR.D., ZhengX.et al.1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest., 97:232–237.
14.
GazdharA., BiliciM., PierogJ.et al.2006. In vivo electroporation and ubiquitin promoter—a protocol for sustained gene expression in the lung. J. Gene Med., 8:910–918.
15.
GazdharA., FachingerP., Van LeerC.et al.2007. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol, 292:L529–L536.
Gharaee-KermaniM., PhanS.H.2005. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr. Pharm. Des., 11:3943–3971.
GongR., RifaiA., TolbertE.M.et al.2003. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J. Am. Soc. Nephrol., 14:3047–3060.
20.
GrossT.J., HunninghakeG.W.2001. Idiopathic pulmonary fibrosis. N. Engl. J. Med., 345:517–525.
21.
GrotegutS., Von SchweinitzD., ChristoforiG., LehembreF.2006. Hepatocyte growth factor induces cell scattering through MAPK/EGR-1-mediated upregulation of Snail. EMBO J., 25:3534–3545.
22.
HamadaN., KuwanoK., YamadaM.et al.2005. Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J. Immunol., 175:1224–1231.
23.
HootK.E., OkaM., HanG.et al.2010. HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. J. Clin. Invest., 120:3606–3616.
24.
HowardS., DerooT., FujitaY., ItasakiN.2011. A positive role of cadherin in Wnt/β-catenin signalling during epithelial–mesenchymal transition. PLoS One, 6:e23899.
25.
HsiaC.C., HydeD.M., OchsM., WeibelE.R.2010. An official research policy statement of the American Thoracic Society/European Respiratory Society: Standards for quantitative assessment of lung structure. Am. J. Respir. Crit. Care Med., 181:394–418.
26.
ItakuraA., KurauchiO., MorikawaS.et al.1997. Involvement of hepatocyte growth factor in formation of bronchoalveolar structures in embryonic rat lung in primary culture. Biochem. Biophys. Res. Commun., 241:98–103.
27.
KasaiH., AllenJ.T., MasonR.M.et al.2005. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)Respir. Res., 6:56.
28.
KimC.-H., KimJ., KahngH., ChoiE.2007. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Ann. Surg. Oncol., 14:1565–1574.
29.
KnudsenL., OchsM.2011. Microscopy-based quantitative analysis of lung structure: Application in diagnosis. Expert Opin. Med. Diagn., 5:319–331.
30.
LendrumA.C., FraserD.S., SliddersW., HendersonR.1962. Studies on the character and staining of fibrin. J. Clin. Pathol., 15:401–413.
31.
LeuenbergerA., GazdharA., HerrmannG.et al.2012. Cell-specific expression of human HGF by alveolar type II cells induces remodeling of septal wall tissue in the lung: A morphometric study. J. Appl. Physiol., 113:799–807.
32.
LiuY., MichalopoulosG.K., ZarnegarR.1993. Molecular cloning and characterization of cDNA encoding mouse hepatocyte growth factor. Biochim. Biophys. Acta, 1216:299–303.
33.
Machado-ArandaD., AdirY., YoungJ.L.et al.2005. Gene transfer of the Na+,K+-ATPase β1 subunit using electroporation increases lung liquid clearance. Am. J. Respir. Crit. Care Med., 171:204–211.
34.
MasonR.J., LeslieC.C., Mccormick-ShannonK.et al.1994. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am. J. Respir. Cell. Mol. Biol., 11:561–567.
35.
MedfordA.R.L.2005. VEGF in idiopathic ILD. Thorax, 60:353–354.
36.
OchsM.2006. A brief update on lung stereology. J. Microsc., 222:188–200.
37.
PiguetP.F., CollartM.A., GrauG.E.et al.1990. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature, 344:245–247.
38.
SakamakiY., MatsumotoK., MizunoS.et al.2002. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am. J. Respir. Cell. Mol. Biol., 26:525–533.
39.
SelmanM., KingT.E., PardoA.2001. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med., 134:136–151.
40.
ShibamotoS., HayakawaM., TakeuchiK.et al.1994. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes. Commun., 1:295–305.
41.
ShiratoriM., MichalopoulosG., ShinozukaH.et al.1995. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am. J. Respir. Cell Mol. Biol., 12:171–180.
42.
ShuklaM.N., RoseJ.L., RayR.et al.2009. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am. J. Respir. Cell Mol. Biol., 40:643–653.
43.
SimeP.J., O'ReillyK.M.2001. Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment. Clin. Immunol., 99:308–319.
44.
SimlerN.R., BrenchleyP.E., HorrocksA.W.et al.2004. Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax, 59:581–585.
45.
Singh-KawP., ZarnegarR., SiegfriedJ.M.1995. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. Am. J. Physiol., 268:L1012–L1020.
46.
SissonT.H., MendezM., ChoiK.et al.2010. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 181:254–263.
47.
TakeichiM.1991. Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251:1451–1455.
TsaoM.S., ZhuH., GiaidA.et al.1993. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ., 4:571–579.
50.
VoelkelN.F., VandivierR.W., TuderR.M.2006. Vascular endothelial growth factor in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol., 290:L209–L221.
51.
WatanabeM., EbinaM., OrsonF.M.et al.2005. Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. Mol. Ther., 12:58–67.
52.
WillisB.C., LieblerJ.M., Luby-PhelpsK.et al.2005. Induction of epithelial–mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: Potential role in idiopathic pulmonary fibrosis. Am. J. Pathol., 166:1321–1332.
53.
WillisB.C., DuboisR.M., BorokZ.2006. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc., 3:377–382.
54.
WoessnerJ.F.Jr.1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys., 93:440–447.
55.
ZavadilJ., BottingerE.P.2005. TGF-β and epithelial-to-mesenchymal transitions. Oncogene, 24:5764–5774.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
